| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 6
| Issue : 2 | Page : 88-96 |
|
|
Hidradenitis suppurativa: A review of available immunotherapeutic agents and advancement in treatment
Ana Preda-Naumescu1, Josiah Sowell1, Hana N Ahmed2, Tiffany T Mayo2, Nabiha Yusuf2
1 University of Alabama at Birmingham School of Medicine, Birmingham, USA
2 Department of Dermatology, School of Medicine, University of Alabama at Birmingham, AL, USA
Correspondence Address:
Nabiha Yusuf
1670, University Boulevard, VH 566A, Birmingham, Alabama
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/cdr.cdr_53_21
|
|
|
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that poses a significant diagnostic, as well as therapeutic, challenge for clinicians. The purpose of this review is to explore current treatment guidelines, as well as the newer, investigative immunotherapies, used in the management of HS. Through a detailed, albeit nonexhaustive, literature review, the most-recently published management guidelines and clinical trials concerning HS therapy were identified and their implication in current and future disease management was explored. An understanding of available treatment options, and what lies on the horizon, is important as researchers and clinicians work toward better understanding this unique disease.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
